Tilray (NASDAQ:TLRY) Stock Price Up 3.5%

Tilray Inc (NASDAQ:TLRY) shares shot up 3.5% during mid-day trading on Wednesday . The company traded as high as $2.46 and last traded at $2.39. 21,563,917 shares were traded during mid-day trading, a decline of 12% from the average session volume of 24,624,719 shares. The stock had previously closed at $2.31.

Tilray Stock Performance

The company has a current ratio of 1.63, a quick ratio of 0.99 and a debt-to-equity ratio of 0.11. The firm has a fifty day moving average price of $1.88 and a 200 day moving average price of $2.00. The firm has a market cap of $1.83 billion, a PE ratio of -1.11 and a beta of 2.30.

Insiders Place Their Bets

In other news, CFO Carl A. Merton purchased 20,000 shares of the company’s stock in a transaction dated Friday, January 12th. The stock was acquired at an average price of $1.87 per share, with a total value of $37,400.00. Following the purchase, the chief financial officer now directly owns 20,000 shares in the company, valued at approximately $37,400. The acquisition was disclosed in a document filed with the SEC, which is available at this link. In other Tilray news, CEO Irwin D. Simon purchased 53,700 shares of the stock in a transaction dated Friday, January 12th. The stock was acquired at an average cost of $1.88 per share, for a total transaction of $100,956.00. Following the acquisition, the chief executive officer now owns 2,033,058 shares in the company, valued at approximately $3,822,149.04. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Carl A. Merton acquired 20,000 shares of Tilray stock in a transaction that occurred on Friday, January 12th. The stock was bought at an average price of $1.87 per share, for a total transaction of $37,400.00. Following the completion of the acquisition, the chief financial officer now owns 20,000 shares in the company, valued at approximately $37,400. The disclosure for this purchase can be found here. Insiders have bought 96,300 shares of company stock valued at $183,210 over the last ninety days. Company insiders own 0.68% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of TLRY. Clear Street Markets LLC purchased a new stake in shares of Tilray in the 3rd quarter valued at approximately $25,000. Macquarie Group Ltd. raised its position in Tilray by 188.8% in the second quarter. Macquarie Group Ltd. now owns 8,540 shares of the company’s stock valued at $27,000 after purchasing an additional 5,583 shares during the period. Oppenheimer & Co. Inc. acquired a new position in Tilray during the fourth quarter worth $27,000. Lake Street Financial LLC purchased a new position in shares of Tilray during the third quarter worth $28,000. Finally, Gainplan LLC acquired a new stake in shares of Tilray in the fourth quarter valued at $28,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.